Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028
Triton
Market Research has estimated the European surgical site infection control
market to show an upward trend in terms of revenue and grow rapidly with a CAGR
of 5.83% in the forecasting years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in this market are:
• The United Kingdom
• Germany
• France
• Russia
• Spain
• Italy
• Rest of Europe countries
Statistics
from Public Health England (PHE) suggest that SSIs accounted for nearly 16% of
the total healthcare-associated infection cases in England in 2013. PHE’s
report stated that, the growing trend of surgical site infections was observed
in large bowel surgeries, knee prosthesis procedures, cholecystectomies, etc.
It also revealed that almost 50% of the causative pathogens of SSIs were
Meticillin-sensitive Staphylococcus aureus (MSSA) and Enterobacteriaceae.
The
Government of the UK is taking serious steps to prevent the occurrence of
surgical site infections in the country. The HCAI & AMR department runs an
SSI surveillance service in the nation. They provide hospitals a protocol and
tools for analyzing data on surgical site infections. Thus, the rising efforts
and preventive measures taken by the government for SSI control are leading the
United Kingdom’s surgical site infection control market on a growth path.
In
France, the overall rate of incidence of SSIs is 20% of the total operations
taking place, according to data from the European CDC. A national-level SSI
surveillance system, known as the RAISIN surveillance system, was implemented
in the country in 1999. The aim of this surveillance system is to ensure that
proper methods for surgical site infection control are being practiced in
France. Such measures are aiding the growth of the French surgical site
infection control market.
Getinge
AB is a healthcare company offering products and services for operating rooms,
sterile reprocessing, cardiovascular procedures, intensive care, and life
sciences. Its business operations are primarily divided into three categories:
Infection Control, Extended Care, and Medical Systems. The company sells its
products under the Lancer, Getinge, Maquet, and ArjoHuntleigh brands. The
Swedish company is headquartered in Gothenburg, Västra Götaland County.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.
MARKET DEFINITION
2.2.
PORTER’S FIVE FORCES MODEL
2.2.1.
THREAT OF NEW ENTRANTS
2.2.2.
THREAT OF SUBSTITUTE PRODUCTS
2.2.3.
BARGAINING POWER OF BUYERS
2.2.4.
BARGAINING POWER OF SUPPLIERS
2.2.5.
COMPETITIVE RIVALRY
2.3.
IMPACT OF COVID-19 ON SURGICAL
SITE INFECTION CONTROL MARKET
2.4.
MARKET ATTRACTIVENESS INDEX
2.5.
VENDOR SCORECARD
2.6.
KEY INSIGHTS
2.7.
MARKET DRIVERS
2.7.1.
ENACTMENT OF THE BEST
INFECTION PREVENTION AND CONTROL PRACTICES
2.7.2.
GROWING AGING POPULATION
2.8.
MARKET RESTRAINTS
2.8.1.
SURGING USE OF OUTPATIENT
PROCEDURES
2.8.2.
INCREASED USAGES OF MEDICAL
DISPOSABLE ITEMS
2.9.
MARKET OPPORTUNITIES
2.9.1.
RISING INCIDENCE OF SURGICAL
PROCEDURES
2.9.2.
SIGNIFICANT RISE IN THE
OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1.
SUPERFICIAL INCISIONAL SSI
4.2.
DEEP INCISIONAL SSI
4.3.
ORGAN OR SPACE SSI
5. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1.
HOSPITALS
5.2.
AMBULATORY SURGICAL CENTERS
6. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. SURGICAL
SITE INFECTION CONTROL MARKET - EUROPE
7.1.
COUNTRY ANALYSIS
7.1.1.
THE UNITED KINGDOM
7.1.2.
GERMANY
7.1.3.
FRANCE
7.1.4.
ITALY
7.1.5.
RUSSIA
7.1.6.
SPAIN
7.1.7.
REST OF EUROPE
8. COMPANY
PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9. RESEARCH
METHODOLOGY & SCOPE
9.1.
RESEARCH SCOPE &
DELIVERABLES
9.1.1.
OBJECTIVES OF STUDY
9.1.2.
SCOPE OF STUDY
9.2.
SOURCES OF DATA
9.2.1.
PRIMARY DATA SOURCES
9.2.2.
SECONDARY DATA SOURCES
9.3.
RESEARCH METHODOLOGY
9.3.1.
EVALUATION OF PROPOSED MARKET
9.3.2.
IDENTIFICATION OF DATA SOURCES
9.3.3.
ASSESSMENT OF MARKET
DETERMINANTS
9.3.4.
DATA COLLECTION
9.3.5.
DATA VALIDATION & ANALYSIS
TABLE
1 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
TABLE
2 VENDOR SCORECARD
TABLE
3 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE
4 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE
5 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE
6EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $
MILLION)
TABLE
7 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
2 TYPES OF HEALTHCARE-ASSOCIATED
INFECTIONS
FIGURE
3 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE
4 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
5 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
6 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)
FIGURE
7 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE
8 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $
MILLION)
FIGURE
9 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
10 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
11 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE
12 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE
13 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE
14 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
15 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
16 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE
17 EUROPE SURGICAL SITE INFECTION CONTROL
MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
18 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE
19 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE
20 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
21 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE
22 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE
23 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
24 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE
25 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE
26 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE
27 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE
28 EUROPE SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE
29 THE UNITED KINGDOM SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
30 GERMANY SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
31 FRANCE SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
32 ITALY SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE
33 RUSSIA SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
34 SPAIN SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE
35 REST OF EUROPE SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)